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SUMMARY: This review highlights the human studies that explore the benefits of  the Mediterranean 
diet and olive oil, based on gene expression analysis. We summarized consistent human transcriptomic 
studies on cardiovascular risk, based on TMD and olive oil interventions, with real life doses and con-
ditions. A literature review was carried out leading up to February 2016. The results show that the 
TMD, specially supplemented with virgin olive oil, produces beneficial changes in the transcriptomic 
response of  relevant genes in cardiovascular risk such as CAT, GPX1 and SIRT2. p65 and MCP-1, IL1B, 
IL6, CXCL1, INF-γ, ARHGAP15 and IL7R, which are involved in inflammation; and ABCA1, SR-B1, 
PPARBP, PPARα, PPARγ, PPARδ, CD-36 and COX-1, which play an important role in cholesterol 
efflux. The available data illustrate a transcriptomic effect on atherosclerosis, inflammation and oxidative 
stress pathways as well as the mentioned genes.
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RESUMEN: Protección cardiovascular de la dieta mediterránea y el aceite de oliva. Una actua­
lización de transcriptómica en humanos. Esta revisión resume los estudios de transcriptómica en huma-
nos que muestran efectos beneficiosos de la dieta mediterránea tradicional (TMD) y el aceite de oliva, 
en condiciones y dosis de la vida real en relación al riesgo cardiovascular. La revisión se llevó a cabo 
hasta febrero de 2016. Los resultados muestran que la TMD, especialmente suplementada con aceite de 
oliva virgen, ejerce cambios beneficiosos en la respuesta transcriptómica de genes relevantes en el riesgo 
cardiovascular tales como CAT, GPX1 y SIRT2. p65 y MCP-1, IL1B, IL6, CXCL1, INF-γ, ARHGAP15 
y IL7R implicados en la inflamación. ABCA1, SR-B1, PPARBP,  PPARα, PPARγ, PPARδ, CD-36 y la 
COX-1 juegan un papel importante en el eflujo de colesterol. Además, ADRB2 está relacionada con el 
estrés oxidativo. Los datos disponibles nos llevan a un efecto transcriptómico sobre las vías de arterio-
sclerosis, inflamación y estrés oxidativo, así como sobre los genes mencionados.
PALABRAS CLAVE: Aceite de oliva; Ácidos grasos monoinsaturados; Cardiovascular; Dieta mediterránea; 
Nutrigenómica; Polifenoles; Transcriptómica
Citation/Cómo citar este artículo: Carrión S, Torres L, Castañer O. 2016. Cardiovascular risk protection from the 
Mediterranean diet and olive oil. A transcriptomic update in humans. Grasas Aceites 67, e161. http://dx.doi.
org/10.3989/gya.0451161.
Copyright: © 2016 CSIC. This is an open-access article distributed under the terms of the Creative Commons 
Attribution (CC-by) Spain 3.0 License.
*This manuscript was presented in the I Workshop INSA-UB “The Universe of the Olive Oil”, in November 2015.
2 • S. Carrión, L. Torres and O. Castañer
Grasas Aceites 67 (4), October-December 2016, e161. ISSN-L: 0017–3495 doi: http://dx.doi.org/10.3989/gya.0451161
ABBREVIATIONS
ABCA1, ATP-Binding Cassette transporter1; 
ADRB2, adrenergic β-2 receptor; ADRB2, 
Adrenoceptor Beta 2; ALA, α-Linolenic  acid; 
AMI, Acute myocardial infarction; AP-1, 
Activator protein-1 transcription factor com-
plex; ApoA-1, Apolipoprotein A1; ARHGAP15, 
Rho GTPase Activating Protein 15; BP, Blood 
pressure; CAT, catalase; CCL2, Chemokine 
(C-C motif) ligand 2; CCL5, Chemokine (C-C 
motif) ligand 5; CD36, Cluster of  differen-
tiation 3; CD-36, cluster of  differentiation  36; 
CD40L, Cluster of  differentiation 4 antigen 
ligand; CHD, Coronary heart disease; CHD, 
Carbohydrate; COX-1; Cyclooxygenase1;CVD, 
Cardiovascular disease; CXCL1, Chemokine 
(C-X-C motif) ligand 1; EFSA, European 
Food Safety Authority; EMR1, EGF-like mod-
ule containing mucin-like hormone receptor; 
eNOS, endothelial nitric oxide synthase; EPA, 
Eicosapentaenoic acid; ET-1, Endothelin-1; 
EUROLIVE , European Study of  the Antioxidant 
Effects of  Olive Oil and its Phenolic Compounds 
on lipid oxidation; FDA, U.S. Food and Drug 
Administration; GPX1, Glutathione peroxidase 
1; GSH/GSSG ratio, Reduced glutathione/oxi-
dized gluthatione; GSR, Glutathione Reductase, 
GSTP1, Glutathione S-transferase P; GWAS, 
Genome-wide association study; HDL, high 
density lipoproteins; IFN-γ, Interferon gamma; 
IL1B, Interleukin-1 beta; IL23A, InterleukinL-
23α subunit p19; IL-6, Interleukine 6; IL7R, 
Interleukin 7 receptor alpha chain; IL8RA, 
Interleukin-8 receptor-α; LDL, low density 
lipoproteins; LPL, lipoprotein lipase; LRP1, 
lipoprotein receptor-related protein 1; MAPKs, 
Mitogen-activated protein kinases; MCP-1, 
Monocyte chemoattractant protein-1; MedDiet, 
Mediterranean Diet; mRNA, messenger RNA; 
MUFA, Monounsaturated fatty acids; NADPH, 
Reduced Nicotinamide adenine dinucleotide 
phosphate; NAFLD, Non-alcoholic fatty liver 
disease; NF-Kb, Transcription factor kappaB; 
NO, nitric oxide; NRF2, Nuclear factor (ery-
throid-derived 2)-like 2; OLR1, oxidized LDL 
(lectin-like) receptor 1; OO, olive oil; OxLDL, 
Oxidized LDL; PBMCs, Peripheral blood mono-
nuclear cells; PCR, Polymerase chain reaction; 
PPARBP, peroxisome proliferator-activated 
receptor binding protein; PPARs, Peroxisome 
proliferator-activated receptors; PPARα, per-
oxisome proliferator-activated receptor alfa; 
PPARγ, peroxisome proliferator-activated recep-
tor betta; PPARδ, peroxisome proliferator-
activated receptor gamma;PPL, Postprandial 
triglyceridemia; PREDIMED, Prevención con 
Dieta Mediterranea; PUFA, Polyunsaturated 
fatty acids; qRT-PCR, quantitative real time-
PCR; ROS, Reactive oxygen species; SBP, 
Systolic blood pressure; SFA, Saturated fatty 
acids; SIRT2, NAD-dependent deacetylase 
sirtuin-2 ;SNPs, Single nucleotide polymor-
phisms; SOD1, Superoxide dismutase 1; SOP, 
Sulphate of  potash; SOX, Dimethylpolysiloxane; 
SR-B1, Scavenger receptor class B member 1; 
TFPI, Tissue factor pathway inhibitor; TMD, 
Traditional Mediterranean Diet; TNF-α, Tumor 
necrosis factor alpha; VOO, Virgin Olive Oil.
1. INTRODUCTION
1.1. The Mediterranean Diet
The Traditional Mediterranean Diet (TMD) 
has been historically associated with good health. 
In 2010, UNESCO officially defined the TMD 
as an intangible cultural heritage of  humanity, 
sensory stimulation, socialization, biodiversity, 
and seasonality, aspects that can reinforce the 
TMD’s beneficial effects on wellbeing, qual-
ity of  life, and health (Bach-Faig et al., 2011; 
UNESCO). It is specifically from countries sur-
rounding the Mediterranean basin. The pyramid 
representation graphically highlights the food 
groups to be consumed since 1995, when this 
healthy pattern was made popular worldwide 
(Willett et al., 1995). The TMD is character-
ized by a high intake of  vegetables, fruits, cere-
als, legumes, and nuts; a moderate to high intake 
of  fish and poultry, low red meat intake, small 
dairy products consumption, and moderate wine 
consumption with meals (Willett et al., 1995). 
Despite all the variants of  the TMD, they all 
share one food component: Olive oil, considered 
the hallmark of  this dietary pattern. Olive oil is 
a natural olive juice and its major components 
are fatty acids: MUFA (55–83%), polyunsatu-
rated fatty acids (PUFA) (4–20%) and satu-
rated fatty acids (SFA) (8–14%) (Tripoli et  al., 
2005). The soluble fraction containing the minor 
olive oil components, such as the phenolic com-
pounds constitutes 1–2% of  the total content 
(Owen et al., 2000). In November 2004, the U.S. 
Food and Drug Administration (FDA) assessed 
a health claim regarding olive oil and coronary 
heart disease (CHD) risk reduction benefits, 
suggesting that “eating about 2 tablespoons (23 
grams) of  olive oil daily could reduce the risk of 
CHD due to the monounsaturated fat (MUFA) 
in olive oil” according to US Food and Drug 
Administration (2004). Later, scientific evidence 
demonstrated that the health effects could also 
be attributed to the olive oil’s phenolic fraction 
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(Granados-Principal et  al., 2010) and, conse-
quently, the European Food Safety Authority 
(EFSA) released a claim concerning the benefits 
of  a daily ingestion of  olive oil rich in phenolic 
compounds, such as VOO. It is considered that 
at least 5 mg of  hydroxytirosol per 20 g of  olive 
oil should be consumed daily in order to support 
the claim (EFSA Journal, 2011).
1.2. Cardiovascular disease and diet
Cardiovascular disease (CVD) represents a 
worldwide burden. Around 17.5 million people 
die each year from CVDs (31% of all deaths) and 
it seems to be rising substantially, due to popula-
tion growth and increased longevity (World Health 
Organization, 2011).
There are several cardiovascular risk factors 
that interact synergistically. Some of  these fac-
tors are preventable, like tobacco use, physical 
inactivity and unhealthy diet. These modifiable 
behaviors are responsible for about 80% of  CVD 
(World Health Organization, 2011). The results 
from randomized primary and secondary pre-
vention clinical trials support the relevance of 
modifying dietary habits. Low fruit and vegeta-
ble consumption produce 2,8% approximately of 
deaths worldwide (World Health Organization, 
2011) while their adequate consumption reduces 
the risk of  CVD (Schröder et al., 2007). It has 
also been evidenced that while saturated fat and 
trans-fat (mainly of  animal origin), increase 
the risk of  coronary heart disease (CHD), the 
replacement with monounsaturated and poly-
unsaturated fat reduces the risk (Estruch et al., 
2013).
According to these facts, it was postulated 
that a TMD intervention reduces cardiovascu-
lar events (acute myocardial infarction, stroke 
and cardiovascular mortality) in individuals at 
high cardiovascular risk (Estruch et al., 1995) 
and reduces recurrences in secondary prevention 
(Lorgeril et al., 1999), as has been demonstrated 
in clinical trials “in vivo”.
Recently, the PREDIMED (Prevención con Dieta 
Mediterranea) study, a primary prevention trial, 
showed that an unrestricted-energy Mediterranean 
diet, supplemented with extra-virgin olive oil or 
nuts, reduced the incidence of major cardiovascu-
lar events by 30% in people at high cardiovascular 
risk (Estruch et al., 2013). Similarly, the Lyon Diet 
Heart Study, a secondary prevention trial, showed a 
47% reduction in rates of CHD events with a modi-
fied Mediterranean diet enriched with alpha-linoleic 
acid, a key constituent of walnuts (Lorgeril et al., 
1999).
1.3. The Mediterranean diet’s effect on oxidation 
and inflammation processes
Atherosclerosis, defined as the loss of plastic-
ity and narrowing of the arterial lumen as a con-
sequence of atherosclerotic plaque development, is 
the main pathophysiological factor related to CVD. 
A number of highly interrelated processes result 
in atherosclerosis; the study of all these processes 
has led to the consideration of new emergent risk 
factors for CVD and novel biomarkers to manage 
this disease. Among these processes, oxidation and 
inflammation play a key role according to Berliner 
(Berliner et al., 1995).
The phenolic compounds in olive oil have proven 
antioxidant and anti-inflammatory properties, as 
well as an improvement in endothelial function 
and the lipid profile (Owen et al., 2000; Zern and 
Fernandez, 2005; Visioli et al., 2000).
The European Study of  the Antioxidant Effects 
of  Olive Oil and its Phenolic Compounds on lipid 
oxidation (EUROLIVE) study (Covas et al., 2006) 
was a clinical trial to evaluate the effects of  the 
phenolic content in olive oil on the plasma lipid 
profile and lipid oxidative damage. The systemic 
markers of  lipid oxidation decreased inversely 
with the phenolic content of  the olive oil (par-
ticularly low density lipoprotein (LDL) oxidation 
markers) and high density lipoprotein (HDL) 
cholesterol levels increased in a direct relation-
ship with the phenolic content of  the olive oil. 
This increase in HDL cholesterol and the decrease 
of  oxidized LDL (oxLDL) in a dose dependent 
manner with the phenolic content of  the olive oil, 
pointed out an independent effect of  the phenolic 
compounds in olive oil (OO) beyond the effect of 
oleic acid. These results indicated that not only 
monounsaturated fatty acids but also the pheno-
lic fraction of  the olive oil had an impact on the 
lipid profile and oxidative damage to lipids. This 
clinical trial was one of  the key reports to provide 
evidence to recommend polyphenol-rich olive oil 
as a source of  fat to achieve additional benefits 
against CVD risk factors.
OxLDL is a key factor in the atherosclerosis 
process. The oxidation of LDL is a pre-requisite 
for macrophage action in the subendothelial space 
(uptake and cellular accumulation of cholesterol) 
one of the prior steps to the formation of the fatty 
streak. Higher serum concentrations of oxLDL have 
been observed in acute myocardial infarction (AMI) 
patients versus controls (Tsimikas et al., 2005) and a 
predictive value has been attributed to oxLDL in the 
general population (Meisinger et al., 2005; Gómez 
et al., 2009).
Nowadays studies focused on HDL report that 
HDL lipoproteins’ functional capacities are more 
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relevant than the mere HDL cholesterol quantity. 
Olive oil polyphenols seem to promote these capaci-
ties, like the cholesterol efflux capacity, improv-
ing HDL antioxidant and inflammatory capacity 
(Hernáez et al., 2016).
1.4. Nutrigenomics
Omic technologies give us a holistic view, 
with integrated information about the molecules 
that make up a cell, tissue or organism (Fito and 
Konstantinidou, 2016). We can distinguish between:
1) Genomics: the systematic study of an organ-
ism’s genome (structure, function, and expression); 
2) Transcriptomics: The transcriptome is the total 
messenger-RNA (mRNA) in a cell or organism and 
the template for protein synthesis in a process called 
translation. The transcriptome reflects the genes that 
are actively expressed at any given moment. Gene 
expression microarrays measure packaged mRNA 
as a summary of gene activity; 3) Proteomics aims to 
characterize the information flow within the cell and 
the organism, through protein pathways and networks, 
with the eventual aim of understanding the functional 
relevance of proteins; 4) Metabolomics: The metabo-
lome is the final downstream product of gene tran-
scription, therefore, changes in the metabolome are 
amplified relative to changes in the transcriptome and 
the proteome (Horgan and Kenny., 2011).
Nutrients and food components have an effect 
on the whole-body physiology and health status at 
a molecular and cellular level. Molecular nutrition 
research has great potential since it can promote 
health and lower mortality and morbidity by deter-
mining the molecular mechanisms that underlay this 
processes.
The DNA microarrays are used to measure the 
DNA sequence or expression differences among 
individuals. It has the capacity to analyze the expres-
sion of thousands of genes simultaneously by mea-
suring the changes in mRNA abundance. In gene 
expression analysis, RNA is extracted from the sam-
ples (normal/control and disease/case samples you 
want to compare), translated to cDNA by a reverse 
transcription process, labeled (addition of fluores-
cent dyes) and hybridized with the microarray slide. 
The cDNA undergoes an amplification process by 
polymerase chain reaction (PCR) and is positioned 
into the solid support of the array (the microarray 
glass sides or chips). There is an ultraviolet laser that 
scans the slide and is able to detect the amount of 
fluorescent signals for each gene, which will depend 
on the expression in each sample. The image is then 
analyzed to determine which gene expressions are 
significantly different. These changes should be then 
validated in all the samples studied using real-time 
PCR (Horgan and Kenny, 2011).
The majority of studies assessing differential 
expression directly undergo real time PCR. In this 
case the genes or pathways analyzed will be the ones 
selected on the basis of a set on genes reported to be 
significant for the studied process or detected to be 
differentially expressed in previous microarray anal-
yses. The real time polymerase chain reaction will 
allow the amplification of all the DNA introduced 
and its simultaneous quantification (Bustin, 2000). 
It is also applied in cDNA reversal transcribed from 
RNA extracted from samples that we want to com-
pare (Konstantinidou et al., 2013).
Clinical intervention trials are a good approach 
for conducting gene-nutrient phenotype association 
studies and the combination of high-throughput 
technologies are clarifying the mechanisms by which 
TMD exerts its beneficial effects on human health.
Our aim was to summarize consistent human 
nutrigenomic studies related to the TMD and olive 
oil intake in a high cardiovascular risk population.
2. MATERIALS AND METHODS
2.1. Literature review
A literature review was carried out in PUBMED. 
We searched for randomized controlled clinical tri-
als assessing the effect of acute or sustained inter-
vention with the TMD or OO consumption on 
the human gene expression related to oxidation/
inflammation-related processes in cardiovascular 
risk. The following MESH terms were submitted: 
(mediterranean diet [Title/Abstract] OR olive oil 
[Title/Abstract]) AND (gene expression [Title/
Abstract] OR transcriptomic* [Title/Abstract] OR 
nutrigenomic* [Title/Abstract]). Studies performed 
in cellular or animal models were excluded; as well 
as those related to cancer or other conditions that 
differ from the ones of our interest. Studies lack-
ing control and/or were not randomized and those 
in which external solutions were used as a supple-
mentation (drugs, pills, antioxidants mix, etc.) were 
also excluded. Table 1 summarizes the main tran-
scriptomic findings obtained in these 16 selected 
studies, as well as the study and intervention design, 
the evaluated constituent and the studied outcome 
and other facts. We have up-dated and summarized 
the available knowledge in the field of nutrigenom-
ics and Mediterranean diet and olive oil intake on 
cardiovascular risk.
3. RESULTS
3.1. Study design and methodology
The TMD as a whole dietary pattern has an 
impact on cardiovascular risk prevention and sev-
eral studies have reported the effects of this diet at a 
molecular level.
The studies are based on the nutrigenomic analy-
sis of different constituents of the TMD; the type of 
Cardiovascular risk protection from the Mediterranean diet and olive oil • 5
Grasas Aceites 67 (4), October-December 2016, e161. ISSN-L: 0017–3495 doi: http://dx.doi.org/10.3989/gya.0451161
R
ef
er
en
ce
T
yp
e 
of
 s
tu
dy
P
ar
ti
ci
pa
nt
s
T
is
su
e
M
ea
su
re
d 
by
In
te
rv
en
ti
on
C
on
st
it
ue
nt
 
ev
al
ua
te
d
S
tu
di
ed
 o
ut
co
m
e
M
ai
n 
tr
an
sc
ri
pt
om
ic
 fi
nd
in
gs
L
lo
re
nt
e-
C
or
te
s 
et
 a
l.,
 2
01
0
R
an
do
m
iz
ed
, 
pa
ra
lle
l, 
co
nt
ro
lle
d,
 d
ou
bl
e-
bl
in
d 
tr
ia
l
49
 h
ig
h 
ca
rd
io
va
sc
ul
ar
 
ri
sk
 p
eo
pl
e
P
B
M
C
s
qR
T
-P
C
R
T
D
M
+
nu
ts
 v
s 
T
D
M
+
V
O
O
 v
s 
L
F
D
3 
m
on
th
s
D
ie
ta
ry
 
pa
tt
er
n
V
as
cu
la
r 
in
fl
am
m
at
io
n,
 fo
am
 
ce
ll 
fo
rm
at
io
n 
an
d 
th
ro
m
bo
si
s
T
he
 c
on
su
m
pt
io
n 
of
 a
 
T
M
D
+
V
O
O
 p
re
ve
nt
s 
th
e 
in
cr
ea
se
 o
f 
C
O
X
-2
 a
nd
 L
R
P
1,
 
an
d 
re
du
ce
s 
M
C
P
-1
 e
xp
re
ss
io
n 
co
m
pa
re
d 
to
 T
M
D
+
nu
ts
 
an
d 
L
F
D
 in
te
rv
en
ti
on
s.
 
T
M
D
+
nu
ts
 in
cr
ea
se
s 
th
e 
ex
pr
es
si
on
 o
f 
C
D
36
 a
nd
 T
F
P
I 
co
m
pa
re
d 
to
 T
M
D
+
V
O
O
 a
nd
 
co
nt
ro
l d
ie
t 
in
te
rv
en
ti
on
.
C
as
ta
ñe
r 
et
 a
l.,
 
20
13
R
an
do
m
iz
ed
, 
pa
ra
lle
l, 
m
ul
ti
ce
nt
er
, 
co
nt
ro
lle
d 
tr
ia
l
34
 h
ig
h 
C
V
D
 
ri
sk
 p
eo
pl
e
(P
R
E
D
IM
E
D
 
su
bs
am
pl
e)
P
B
M
C
s
qR
T
-P
C
R
m
ic
ro
ar
ra
y
T
D
M
+
nu
ts
 v
s 
T
D
M
+
V
O
O
 v
s 
 
L
F
D
3 
m
on
th
s
D
ie
ta
ry
 
pa
tt
er
n
C
D
V
 r
is
k 
si
gn
al
in
g 
pa
th
w
ay
s
T
he
 c
on
su
m
pt
io
n 
of
 T
M
D
 
pr
od
uc
es
 c
ha
ng
es
 in
 k
ey
 
pa
th
w
ay
s 
su
ch
 a
s 
hy
po
xi
a 
an
d 
eN
O
S 
si
gn
al
in
g.
 
A
th
er
os
cl
er
os
is
, r
en
in
-
an
gi
ot
en
si
n,
 n
it
ri
c 
ox
id
e 
an
d 
an
gi
op
oi
et
in
 s
ig
na
lin
g,
 a
re
 
on
ly
 m
od
ul
at
ed
 b
y 
th
e 
T
M
D
 
en
ri
ch
ed
 w
it
h 
V
O
O
.
St
or
ni
ol
o 
et
 a
l.,
 
20
15
R
an
do
m
iz
ed
, 
pa
ra
lle
l, 
m
ul
ti
ce
nt
er
, 
co
nt
ro
lle
d 
tr
ia
l
90
 h
ig
h 
C
V
D
 
ri
sk
 a
nd
 
m
od
er
at
e 
hy
pe
rt
en
si
on
 
w
om
en
(P
R
E
D
IM
E
D
 
su
bs
am
pl
e)
P
B
M
C
s
qR
T
-P
C
R
m
ic
ro
ar
ra
y
T
D
M
+
nu
ts
 v
s 
T
D
M
+
V
O
O
 v
s 
 
L
F
D
3 
m
on
th
s
D
ie
ta
ry
 
pa
tt
er
n
B
lo
od
 p
re
ss
ur
e 
T
he
 c
on
su
m
pt
io
n 
of
 a
 
T
M
D
+
V
O
O
 p
ro
du
ce
s 
up
-r
eg
ul
at
io
n 
of
 N
O
 a
nd
 
eN
O
S 
ge
ne
 e
xp
re
ss
io
n 
an
d 
th
e 
co
ns
um
pt
io
n 
of
 a
 T
M
D
 
di
et
+
nu
ts
 p
ro
du
ce
s 
do
w
n-
re
gu
la
ti
on
 o
f 
E
T
-1
 a
nd
 E
T
-1
 
re
ce
pt
or
 g
en
e 
ex
pr
es
si
on
. 
T
he
se
 g
en
es
 a
re
 r
el
at
ed
 t
o 
en
do
th
el
ia
l d
ys
fu
nc
ti
on
 a
nd
 
hy
pe
rt
en
si
on
 a
nd
 t
he
ir
 c
ha
ng
es
 
ar
e 
as
so
ci
at
ed
 t
o 
a 
re
du
ce
d 
B
P.
D
i R
en
zo
 e
t 
al
., 
20
14
R
an
do
m
iz
ed
, 
cr
os
so
ve
r, 
co
nt
ro
lle
d,
 
po
st
pr
an
di
al
 t
ri
al
24
 h
ea
lt
hy
 
pe
op
le
P
B
M
C
s
qR
T
-P
C
R
M
ea
ls
:
M
cD
 v
s 
T
M
D
 +
/-
 
re
d 
w
in
e
R
ed
 w
in
e 
po
ly
ph
en
ol
s
L
D
L
, o
xi
da
ti
on
 a
nd
 
in
fl
am
m
at
io
n
T
he
 c
on
su
m
pt
io
n 
of
 r
ed
 w
in
e 
as
so
ci
at
ed
 w
it
h 
di
ff
er
en
t 
m
ea
l 
ty
pe
s 
in
cr
ea
se
s 
an
ti
ox
id
an
t 
ex
pr
es
si
on
 o
f 
ge
ne
s 
su
ch
 a
s 
C
A
T,
 G
P
X
1 
an
d 
SI
R
T
2,
 a
nd
 
de
cr
ea
se
s 
C
C
L
5 
(i
nv
ol
ve
d 
in
 
im
m
un
e 
an
d 
in
fl
am
m
at
or
y 
pr
oc
es
se
s)
 g
en
e 
ex
pr
es
si
on
.
T
a
b
l
e
 1
. 
Su
m
m
ar
y 
of
 f
in
di
ng
s 
of
 n
ut
ri
ge
no
m
ic
s 
ef
fe
ct
s 
fr
om
 o
liv
e 
oi
l a
nd
 M
ed
it
er
ra
ne
an
 d
ie
t
6 • S. Carrión, L. Torres and O. Castañer
Grasas Aceites 67 (4), October-December 2016, e161. ISSN-L: 0017–3495 doi: http://dx.doi.org/10.3989/gya.0451161
R
ef
er
en
ce
T
yp
e 
of
 s
tu
dy
P
ar
ti
ci
pa
nt
s
T
is
su
e
M
ea
su
re
d 
by
In
te
rv
en
ti
on
C
on
st
it
ue
nt
 
ev
al
ua
te
d
S
tu
di
ed
 o
ut
co
m
e
M
ai
n 
tr
an
sc
ri
pt
om
ic
 fi
nd
in
gs
P
er
ez
 H
er
re
ra
  
et
 a
l.,
 2
01
3
R
an
do
m
iz
ed
 
cr
os
so
ve
r, 
co
nt
ro
lle
d,
 
po
st
pr
an
di
al
 t
ri
al
20
 o
be
se
 p
eo
pl
e
P
B
M
C
s
qR
T
-P
C
R
H
ea
te
d 
oi
l-
ba
se
d 
br
ea
kf
as
ts
:
V
O
O
 v
s 
SF
O
 v
s 
SF
O
/c
an
ol
a
+
SO
X
/S
O
P
N
at
ur
al
 a
nd
 
ar
ti
fi
ci
al
ly
 
ad
de
d 
an
ti
ox
id
an
ts
O
xi
da
ti
ve
 s
tr
es
s
T
he
 c
on
su
m
pt
io
n 
of
 o
ils
 w
it
h 
na
tu
ra
l o
r 
ar
ti
fi
ci
al
 a
nt
io
xi
da
nt
 
(S
O
X
),
 r
ed
uc
es
 p
os
tp
ra
nd
ia
l 
ox
id
at
iv
e 
st
re
ss
 c
om
pa
re
d 
w
it
h 
su
nf
lo
w
er
 o
il 
ev
en
 a
ft
er
 a
 d
ee
p-
fr
yi
ng
 p
ro
ce
ss
. T
he
 in
ta
ke
 o
f 
SF
O
 in
cr
ea
se
s 
ge
ne
 e
xp
re
ss
io
n 
of
 d
iff
er
en
t 
N
A
D
P
H
-o
xi
da
se
 
su
bu
ni
ts
 (
R
O
S 
ge
ne
ra
ti
ng
 
en
zy
m
e)
, t
hu
s 
in
cr
ea
si
ng
 t
he
 
ge
ne
 e
xp
re
ss
io
n 
of
 a
nt
io
xi
da
nt
 
en
zy
m
es
 N
R
F
2,
 S
O
D
1,
 C
A
T,
 
G
ST
P
1,
 T
X
N
 a
nd
 G
SR
, a
nd
 
ca
us
in
g 
an
 im
ba
la
nc
e 
in
 t
he
 
G
SH
/G
SS
G
 r
at
io
 (
ox
id
at
iv
e 
st
re
ss
).
K
on
st
an
ti
ni
do
u 
et
 a
l.,
 2
01
0
R
an
do
m
iz
ed
, 
pa
ra
lle
l, 
co
nt
ro
lle
d,
 d
ou
bl
e-
bl
in
d 
tr
ia
l
90
 h
ea
lt
hy
 
pe
op
le
(2
6 
m
en
 a
nd
 6
4 
w
om
en
)
P
B
M
C
s
qR
T
-P
C
R
T
M
D
+
V
O
O
 (
H
P
C
) 
vs
 T
M
D
+
w
as
he
d 
V
O
O
 (
W
O
O
-L
P
C
) 
vs
 c
on
tr
ol
O
O
 p
he
no
lic
 
co
nt
en
t
In
fl
am
m
at
io
n 
an
d 
ox
id
at
iv
e 
st
re
ss
T
he
 c
on
su
m
pt
io
n 
of
 
T
M
D
+
V
O
O
 d
ec
re
as
es
 t
he
 
ge
ne
 e
xp
re
ss
io
n 
of
 I
N
F
-γ
,  
A
R
H
G
A
P
15
 a
nd
 I
L
7R
 
(r
el
at
ed
 t
o 
in
fl
am
m
at
io
n)
 a
nd
 
A
D
R
B
2 
(o
xi
da
ti
ve
 s
tr
es
s)
H
er
ná
ez
 e
t 
al
., 
20
15
R
an
do
m
iz
ed
, 
cr
os
so
ve
r, 
co
nt
ro
lle
d,
 d
ou
bl
e-
bl
in
d 
tr
ia
l
18
 h
ea
lt
hy
 m
en
(E
U
R
O
L
IV
E
 
su
bs
am
pl
e)
P
B
M
C
s
qR
T
-P
C
R
25
 m
L
/d
ay
 O
O
:
H
P
C
 v
s 
L
P
C
3-
w
ee
k 
pe
ri
od
O
O
 p
he
no
lic
 
co
nt
en
t
L
D
L
T
he
 c
on
su
m
pt
io
n 
of
 p
he
no
l-
ri
ch
 O
O
 in
cr
ea
se
s 
L
P
L
 g
en
e 
ex
pr
es
si
on
 c
om
pa
re
d 
to
 t
he
 
L
P
C
O
O
 in
te
rv
en
ti
on
M
ar
tí
n-
P
el
áe
z 
et
 a
l.,
 2
01
5
R
an
do
m
iz
ed
, 
cr
os
so
ve
r 
co
nt
ro
lle
d,
 d
ou
bl
e-
bl
in
d 
tr
ia
l
18
 h
ea
lt
hy
 m
en
(E
U
R
O
L
IV
E
 
su
bs
am
pl
e)
P
B
M
C
s
qR
T
-P
C
R
25
 m
L
/d
ay
 O
O
:
H
P
C
 v
s 
L
P
C
3-
w
ee
k 
pe
ri
od
O
O
 p
he
no
lic
 
co
nt
en
t
B
lo
od
 p
re
ss
ur
e
T
he
 c
on
su
m
pt
io
n 
of
 
ph
en
ol
-r
ic
h 
O
O
 in
du
ce
s 
ge
ne
 e
xp
re
ss
io
n 
m
od
ul
at
io
n 
of
 t
he
 r
en
in
–a
ng
io
te
ns
in
– 
al
do
st
er
on
e 
sy
st
em
. H
P
C
 
de
cr
ea
se
s 
A
C
E
 (
B
P
) 
an
d 
N
R
1H
2 
(l
ip
id
 h
om
eo
st
as
is
 a
nd
 
in
fl
am
m
at
io
n)
 g
en
e 
ex
pr
es
si
on
 
co
m
pa
re
d 
w
it
h 
ba
se
lin
e,
 a
nd
 
IL
8R
A
 (
ce
ll 
gr
ow
th
) 
ge
ne
 
ex
pr
es
si
on
 c
om
pa
re
d 
w
it
h 
L
P
C
 
in
te
rv
en
ti
on
.
C
as
ta
ñe
r 
et
 a
l.,
 
20
12
R
an
do
m
iz
ed
, 
cr
os
so
ve
r, 
co
nt
ro
lle
d 
tr
ia
l
18
 h
ea
lt
hy
 m
en
(E
U
R
O
L
IV
E
 
su
bs
am
pl
e)
P
B
M
C
s
qR
T
-P
C
R
25
 m
L
/d
ay
 O
O
:
H
P
C
 v
s 
L
P
C
3-
w
ee
k 
pe
ri
od
O
O
 p
he
no
lic
 
co
nt
en
t
L
D
L
 o
xi
da
ti
on
 a
nd
 
C
D
40
L
 e
xp
re
ss
io
n
T
he
 c
on
su
m
pt
io
n 
of
 p
he
no
l-
ri
ch
 O
O
 r
ed
uc
es
 t
he
 e
xp
re
ss
io
n 
of
 p
ro
-a
th
er
og
en
ic
 g
en
es
. 
D
ow
n-
re
gu
la
ti
on
 o
f 
C
D
40
-L
 
ex
pr
es
si
on
 a
nd
 it
s 
do
w
ns
tr
ea
m
 
pr
od
uc
ts
: C
D
40
L
, I
L
23
A
, 
A
D
R
B
2,
 O
L
R
1,
 a
nd
 I
L
8R
A
T
a
b
l
e
 1
. 
(C
on
ti
nu
ed
)
Cardiovascular risk protection from the Mediterranean diet and olive oil • 7
Grasas Aceites 67 (4), October-December 2016, e161. ISSN-L: 0017–3495 doi: http://dx.doi.org/10.3989/gya.0451161
R
ef
er
en
ce
T
yp
e 
of
 s
tu
dy
P
ar
ti
ci
pa
nt
s
T
is
su
e
M
ea
su
re
d 
by
In
te
rv
en
ti
on
C
on
st
it
ue
nt
 
ev
al
ua
te
d
S
tu
di
ed
 o
ut
co
m
e
M
ai
n 
tr
an
sc
ri
pt
om
ic
 fi
nd
in
gs
F
ar
rà
s 
et
 a
l.,
 
20
13
R
an
do
m
iz
ed
, 
cr
os
so
ve
r, 
co
nt
ro
lle
d 
tr
ia
l
13
 p
re
-
hy
pe
rt
en
si
ve
 
pe
op
le
W
B
C
qR
T
-P
C
R
30
 m
l/d
ay
 O
O
:
H
P
C
 v
s 
M
P
C
3-
w
ee
k 
pe
ri
od
O
O
 p
he
no
lic
 
co
nt
en
t
C
ho
le
st
er
ol
 e
ff
lu
x 
T
he
 c
on
su
m
pt
io
n 
of
 
ph
en
ol
-r
ic
h 
O
O
 p
ro
du
ce
s 
up
-r
eg
ul
at
io
n 
of
 t
he
 e
xp
re
ss
io
n 
of
 c
ho
le
st
er
ol
 e
ff
lu
x 
fr
om
 c
el
ls
 
to
 H
D
L
 r
el
at
ed
 g
en
es
 A
B
C
A
1,
 
SR
-B
1,
 P
PA
R
B
P,
 P
PA
R
α
, 
P
PA
R
γ, 
P
PA
R
δ,
 C
D
-3
6 
an
d 
C
O
X
-1
.
C
am
ar
go
 e
t 
al
., 
20
14
R
an
do
m
iz
ed
 
cr
os
so
ve
r, 
co
nt
ro
lle
d,
 
po
st
pr
an
di
al
 t
ri
al
49
 m
et
ab
ol
ic
 
sy
nd
ro
m
e 
pe
op
le
 (
19
 m
en
/ 
30
 w
om
en
)
P
B
M
C
s
qR
T
-P
C
R
V
O
O
-b
as
ed
 
br
ea
kf
as
ts
 a
ft
er
 
C
H
O
 d
ie
t:
H
P
C
 v
s 
M
P
C
 v
s 
L
P
C
6-
w
ee
k 
pe
ri
od
O
O
 p
he
no
lic
 
co
nt
en
t
L
ip
op
ol
ys
ac
ch
ar
id
es
 
an
d 
in
fl
am
m
at
io
n
T
he
 c
on
su
m
pt
io
n 
of
 p
he
no
l-
ri
ch
 V
O
O
 li
m
it
s 
th
e 
in
cr
ea
se
 
of
 I
L
6,
IL
1B
 a
nd
 C
X
C
L
1 
ge
ne
 
ex
pr
es
si
on
, r
ed
uc
in
g 
th
e 
po
st
pr
an
di
al
 in
fl
am
m
at
or
y 
re
sp
on
se
 in
 a
ss
oc
ia
ti
on
 w
it
h 
pl
as
m
a 
lip
op
ol
ys
ac
ch
ar
id
e 
le
ve
ls
.
 C
am
ar
go
 e
t 
al
., 
20
10
R
an
do
m
iz
ed
, 
pa
ra
lle
l, 
co
nt
ro
lle
d,
 d
ou
bl
e-
bl
in
d,
 p
os
tp
ra
nd
ia
l 
tr
ia
l
20
 m
et
ab
ol
ic
 
sy
nd
ro
m
e 
pe
op
le
P
B
M
C
s
Tw
o-
co
lo
r 
m
ic
ro
ar
ra
y 
(A
gi
le
nt
)
V
O
O
-b
as
ed
 
br
ea
kf
as
ts
:
H
P
C
 v
s 
L
P
C
O
O
 p
he
no
lic
 
co
nt
en
t
In
fl
am
m
at
io
n
T
he
 c
on
su
m
pt
io
n 
of
 p
he
no
l-
ri
ch
 V
O
O
 s
ee
m
 t
o 
re
pr
es
s 
ge
ne
s 
in
vo
lv
ed
 in
 in
fl
am
m
at
or
y 
pr
oc
es
se
s 
m
ed
ia
te
d 
by
 N
F
-k
B
, 
A
P
-1
, c
yt
ok
in
es
, M
A
P
K
s 
or
 
ar
ac
hi
do
ni
c 
ac
id
 p
at
hw
ay
s.
B
el
lid
o 
et
 a
l.,
 
20
04
R
an
do
m
iz
ed
, 
cr
os
so
ve
r, 
co
nt
ro
lle
d,
 
po
st
pr
an
di
al
 t
ri
al
8 
he
al
th
y 
m
en
P
B
M
C
s
E
M
SA
F
at
ty
 m
ea
l:
O
O
 (
M
U
FA
) 
vs
 b
ut
te
r 
(S
FA
) 
vs
 w
al
nu
t 
(M
U
FA
-S
FA
-P
U
FA
)
af
te
r 
4-
w
ee
k 
ba
se
lin
e 
di
et
D
ie
ta
ry
 f
at
 
co
m
po
si
ti
on
Im
m
un
e,
 a
nd
 
in
fl
am
m
at
or
y 
re
sp
on
se
s 
an
d 
ox
id
at
iv
e 
st
re
ss
T
he
 c
on
su
m
pt
io
n 
of
 M
U
FA
-
ri
ch
 f
at
 a
s 
O
O
 d
o 
no
t 
el
ic
it
 
th
e 
po
st
pr
an
di
al
 a
ct
iv
at
io
n 
of
 N
F
-k
B
 c
om
pa
re
d 
w
it
h 
th
e 
SF
A
-r
ic
h 
an
d 
P
U
FA
-
ri
ch
 m
ea
ls
. N
o 
di
ff
er
en
ce
 in
 
po
st
pr
an
di
al
 t
ry
ac
ilg
lic
er
ol
s.
 J
im
en
ez
-
G
om
ez
 e
t 
al
., 
20
09
R
an
do
m
iz
ed
, 
cr
os
so
ve
r, 
co
nt
ro
lle
d,
 
po
st
pr
an
di
al
 t
ri
al
20
 h
ea
lt
hy
 m
en
P
B
M
C
s
qR
T
-P
C
R
F
at
ty
 b
re
ak
fa
st
 a
ft
er
:
T
D
M
 v
s 
W
es
te
rn
 
vs
 C
H
O
-r
ic
h 
vs
 n
-3
 
di
et
s
D
ie
ta
ry
 f
at
 
co
m
po
si
ti
on
In
fl
am
m
at
io
n
T
he
 c
on
su
m
pt
io
n 
of
 a
 
bu
tt
er
 b
re
ak
fa
st
 in
du
ce
s 
a 
hi
gh
er
 in
cr
ea
se
 in
 t
um
or
 
ne
cr
os
is
 f
ac
to
r 
(T
N
F
)-
α
 
ex
pr
es
si
on
 t
ha
n 
th
e 
ol
iv
e 
oi
l 
or
 w
al
nu
t 
br
ea
kf
as
ts
. A
 h
ig
he
r 
po
st
pr
an
di
al
 r
es
po
ns
e 
of
 
IL
-6
 w
it
h 
th
e 
in
ta
ke
 o
f 
bu
tt
er
 
an
d 
ol
iv
e 
oi
l b
re
ak
fa
st
s 
th
an
 
w
it
h 
th
e 
w
al
nu
t 
br
ea
kf
as
t.
 
H
ow
ev
er
, t
he
 e
ff
ec
ts
 o
f 
th
e 
th
re
e 
fa
tt
y 
br
ea
kf
as
ts
 o
n 
th
e 
pl
as
m
a 
co
nc
en
tr
at
io
ns
 o
f 
th
es
e 
pr
o-
in
fl
am
m
at
or
y 
pa
ra
m
et
er
s 
sh
ow
ed
 n
o 
si
gn
if
ic
an
t 
di
ff
er
en
ce
s.
T
a
b
l
e
 1
. 
(C
on
ti
nu
ed
)
8 • S. Carrión, L. Torres and O. Castañer
Grasas Aceites 67 (4), October-December 2016, e161. ISSN-L: 0017–3495 doi: http://dx.doi.org/10.3989/gya.0451161
R
ef
er
en
ce
T
yp
e 
of
 s
tu
dy
P
ar
ti
ci
pa
nt
s
T
is
su
e
M
ea
su
re
d 
by
In
te
rv
en
ti
on
C
on
st
it
ue
nt
 
ev
al
ua
te
d
S
tu
di
ed
 o
ut
co
m
e
M
ai
n 
tr
an
sc
ri
pt
om
ic
 fi
nd
in
gs
M
ez
a-
M
ir
an
da
 
an
d 
C
am
ar
go
  
et
 a
l.,
 2
01
4
R
an
do
m
iz
ed
, 
cr
os
so
ve
r, 
co
nt
ro
lle
d,
 
po
st
pr
an
di
al
 tr
ia
l
20
 h
ea
lth
y 
el
de
rly
 p
eo
pl
e 
(1
0 
m
en
/1
0 
w
om
en
)
A
di
po
se
 
tis
su
e
qR
T-
PC
R
B
re
ak
fa
st
 a
fte
r:
SF
A
-r
ic
h 
vs
 
TM
D
+V
O
O
(M
U
FA
) 
vs
 C
H
O
-P
U
FA
 d
ie
t
4-
w
ee
k 
pe
rio
d
D
ie
ta
ry
 fa
t 
co
m
po
si
tio
n
O
xi
da
tiv
e 
st
re
ss
Th
e 
co
ns
um
pt
io
n 
of
 T
M
D
 a
nd
 
C
H
O
-P
U
FA
 d
ie
t i
nc
re
as
es
 th
e 
po
st
pr
an
di
al
 g
en
e 
ex
pr
es
si
on
 
pr
of
ile
 o
f t
he
 a
nt
io
xi
da
nt
 
de
fe
ns
e 
sy
st
em
 (r
eg
ul
at
ed
 b
y 
th
e 
N
rf
2 
tra
ns
cr
ip
tio
n 
fa
ct
or
), 
an
d 
th
er
ef
or
e 
R
O
S 
de
to
xi
fic
at
io
n 
ra
te
 in
 th
e 
ad
ip
os
e 
tis
su
e.
C
am
ar
go
 e
t 
al
., 
20
12
R
an
do
m
iz
ed
, 
cr
os
so
ve
r, 
co
nt
ro
lle
d,
 
po
st
pr
an
di
al
 tr
ia
l
20
 h
ea
lth
y 
el
de
rly
 p
eo
pl
e 
(1
0 
m
en
/1
0 
w
om
en
)
PB
M
C
s
qR
T-
PC
R
B
re
ak
fa
st
 a
fte
r:
SF
A
-r
ic
h 
vs
 
TM
D
+V
O
O
(M
U
FA
) 
vs
 C
H
O
-P
U
FA
 d
ie
t
3-
w
ee
k 
pe
rio
d
D
ie
ta
ry
 fa
t 
co
m
po
si
tio
n 
In
fla
m
m
at
io
n
Th
e 
co
ns
um
pt
io
n 
of
 T
M
D
 
re
du
ce
s t
he
 e
xp
re
ss
io
n 
of
 se
ve
ra
l 
in
fla
m
m
at
or
y 
ge
ne
s c
om
pa
re
d 
w
ith
 S
FA
-r
ic
h 
(p
65
 a
nd
 M
C
P-
1)
 
an
d 
C
H
O
-P
U
FA
 d
ie
ts
 (p
65
 a
nd
 
TN
F-
a)
, i
nc
re
as
es
 th
e 
ex
pr
es
si
on
 
of
 th
e 
an
ti-
in
fla
m
m
at
or
y 
ge
ne
 
Ik
B
a 
an
d 
de
cr
ea
se
s t
he
 M
M
P-
9 
pl
aq
ue
 in
st
ab
ili
ty
 m
ar
ke
r g
en
e 
ex
pr
es
si
on
.
A
B
C
A
1,
 A
T
P
-B
in
di
ng
 C
as
se
tt
e 
tr
an
sp
or
te
r1
; 
A
C
E
, 
an
gi
ot
en
si
n-
co
nv
er
ti
ng
 e
nz
ym
e;
 a
C
O
X
-1
, 
P
er
ox
is
om
al
 a
cy
l-
co
en
zy
m
e 
A
 o
xi
da
se
; 
A
D
R
B
2,
 a
dr
en
er
gi
c 
β-2
 r
ec
ep
to
r;
 A
P
-1
, 
A
ct
iv
at
or
 p
ro
te
in
-1
 t
ra
ns
cr
ip
ti
on
 f
ac
to
r 
co
m
pl
ex
; 
A
R
H
G
A
P
15
, 
R
ho
 G
T
P
as
e 
A
ct
iv
at
in
g 
P
ro
te
in
 1
5;
 B
P,
 b
lo
od
 p
re
ss
ur
e;
 C
A
T,
 c
at
al
as
e;
 C
C
L
5,
 C
he
m
ok
in
e 
(C
-C
 m
ot
if
) 
lig
an
d 
5;
 
C
V
D
 c
ar
di
ov
as
cu
la
r 
ri
sk
; C
D
36
, C
lu
st
er
 o
f 
di
ff
er
en
ti
at
io
n 
3;
 C
D
40
L
, C
D
40
 a
nt
ig
en
 li
ga
nd
; C
H
O
, c
ar
bo
hy
dr
at
e;
 C
X
C
L
, c
he
m
ok
in
e 
(C
-X
-C
 m
ot
if
) l
ig
an
d 
1;
 e
N
O
S,
 e
nd
ot
he
lia
l N
O
 
sy
nt
ha
se
; E
T
-1
, e
nd
ot
el
in
-1
; E
U
R
O
L
IV
E
, E
ur
op
ea
n 
St
ud
y 
of
 t
he
 A
nt
io
xi
da
nt
 E
ff
ec
ts
 o
f 
O
liv
e 
O
il 
an
d 
it
s 
P
he
no
lic
 C
om
po
un
ds
 o
n 
lip
id
 o
xi
da
ti
on
; G
SH
/G
SS
G
, o
xi
di
ze
d/
re
du
ce
d 
gl
ut
at
hi
on
e 
ra
ti
o;
 G
SR
, 
gl
ut
at
hi
on
e-
di
su
lf
id
e 
re
du
ct
as
e;
 G
ST
P
1,
 G
lu
ta
th
io
ne
 S
-t
ra
ns
fe
ra
se
 P
; 
G
P
X
1,
 G
lu
ta
th
io
ne
 p
er
ox
id
as
e 
1;
 H
P
C
, 
hi
gh
 p
he
no
lic
 c
on
te
nt
; 
L
D
L
, 
lo
w
 d
en
si
ty
 
lip
op
ro
te
in
; 
L
F
D
, 
lo
w
 f
at
 d
ie
t;
 I
L
1B
, 
In
te
rl
eu
ki
n-
1 
be
ta
; 
IL
6,
 I
nt
er
le
uk
in
-6
; 
IL
7R
, 
In
te
rl
eu
ki
n 
7 
re
ce
pt
or
 a
lp
ha
 c
ha
in
; 
IL
8R
A
, 
In
te
rl
eu
ki
n 
8 
re
ce
pt
or
, 
al
ph
a;
 L
P
C
, 
lo
w
 p
he
no
lic
 
co
nt
en
t;
 L
P
C
O
O
, l
ow
 p
he
no
lic
 c
on
te
nt
 o
liv
e 
oi
l; 
L
R
P
1,
 li
po
pr
ot
ei
n 
re
ce
pt
or
-r
el
at
ed
 p
ro
te
in
 1
; M
A
P
K
s,
 M
it
og
en
-a
ct
iv
at
ed
 p
ro
te
in
 k
in
as
es
; M
cD
, M
cD
on
al
ds
; M
C
P
-1
, M
on
oc
yt
e 
ch
em
oa
tt
ra
ct
an
t 
pr
ot
ei
n-
1;
 N
F
-j
B
, n
uc
le
ar
 f
ac
to
r 
ka
pp
a-
lig
ht
-c
ha
in
-e
nh
an
ce
r 
of
 a
ct
iv
at
ed
 B
 c
el
ls
; M
M
P
-9
, M
at
ri
x 
M
et
al
lo
pe
pt
id
as
e 
9;
 M
P
C
, m
od
er
at
e 
ph
en
ol
ic
 c
on
te
nt
; M
U
FA
, 
m
on
ou
ns
at
ur
at
ed
 f
at
ty
 a
ci
ds
; 
N
A
D
P
H
, 
re
du
ce
d 
N
ic
ot
in
am
id
e 
ad
en
in
e 
di
nu
cl
eo
ti
de
 p
ho
sp
ha
te
; 
N
A
D
P
H
-o
xi
da
se
, 
ni
co
ti
na
m
id
e 
ad
en
in
e 
di
nu
cl
eo
ti
de
 p
ho
sp
ha
te
-o
xi
da
se
; 
N
R
F
2,
 
N
uc
le
ar
 fa
ct
or
 (e
ry
th
ro
id
-d
er
iv
ed
 2
)-
lik
e 
2;
 N
rf
2,
 N
uc
le
ar
 fa
ct
or
 (e
ry
th
ro
id
-d
er
iv
ed
 2
)-
lik
e 
2,
 N
F
-k
B
, n
uc
le
ar
 fa
ct
or
 k
ap
pa
-l
ig
ht
-c
ha
in
-e
nh
an
ce
r 
of
 a
ct
iv
at
ed
 B
 c
el
ls
; N
R
1H
2,
 N
uc
le
ar
 
R
ec
ep
to
r 
Su
bf
am
ily
 1
, G
ro
up
 H
, M
em
be
r 
2;
 N
F
-k
B
, T
ra
ns
cr
ip
ti
on
 fa
ct
or
 k
ap
pa
B
; N
F
-j
B
, n
uc
le
ar
 fa
ct
or
 k
ap
pa
-l
ig
ht
-c
ha
in
-e
nh
an
ce
r 
of
 a
ct
iv
at
ed
 B
 c
el
ls
; N
O
, s
er
um
 n
it
ri
c 
ox
id
e;
 O
O
, 
ol
iv
e 
oi
l; 
ox
-L
D
L
, o
xi
di
ze
d 
L
D
L
; P
B
M
C
s,
 p
er
ip
he
ra
l b
lo
od
 m
on
on
uc
le
ar
 c
el
ls
; P
PA
R
B
P
; P
PA
R
α
, p
er
ox
is
om
e 
pr
ol
if
er
at
or
-a
ct
iv
at
ed
 r
ec
ep
to
r 
al
fa
; P
PA
R
γ, 
pe
ro
xi
so
m
e 
pr
ol
if
er
at
or
-
ac
ti
va
te
d 
re
ce
pt
or
 b
et
ta
; 
P
PA
R
δ,
 p
er
ox
is
om
e 
pr
ol
if
er
at
or
-a
ct
iv
at
ed
 r
ec
ep
to
r 
ga
m
m
a;
 P
R
E
D
IM
E
D
, 
pr
ev
en
ci
ón
 c
on
 d
ie
ta
 M
ed
it
er
ra
ne
a;
 P
U
FA
, 
po
ly
un
sa
tu
ra
te
d 
fa
tt
y 
ac
id
s;
 p
65
, 
pr
ot
ei
n 
65
; q
-R
T
-P
C
R
, q
ua
nt
it
at
iv
e 
re
al
 ti
m
e 
po
ly
m
er
as
e 
ch
ai
n 
re
ac
ti
on
; S
FA
, s
at
ur
at
ed
 fa
tt
y 
ac
id
s;
 S
F
O
, s
un
 fl
ow
er
 o
il;
 S
R
-B
1,
 S
ca
ve
ng
er
 r
ec
ep
to
r 
cl
as
s 
B
 m
em
be
r 
1;
SI
R
T
2,
 N
A
D
-
de
pe
nd
en
t 
de
ac
et
yl
as
e 
si
rt
ui
n-
2;
 S
O
D
1,
 s
up
er
ox
id
e 
di
sm
ut
as
e 
1;
 S
O
C
S3
, S
up
pr
es
so
r 
of
 c
yt
ok
in
e 
si
gn
al
in
g 
3;
 S
O
P,
 S
ul
ph
at
e 
of
 p
ot
as
h;
 S
O
X
, d
im
et
hy
lp
ol
ys
ilo
xa
ne
; T
L
R
4,
 T
ol
l-
lik
e 
re
ce
pt
or
 4
; T
M
D
, t
ra
di
ti
on
al
 M
ed
it
er
ra
ne
an
 d
ie
t;
 V
O
O
, v
ir
gi
n 
ol
iv
e 
oi
l; 
T
F
P
I,
 T
is
su
e 
fa
ct
or
 p
at
hw
ay
 in
hi
bi
to
r;
 T
N
F
-a
, t
um
or
 n
ec
ro
si
s 
fa
ct
or
 a
lp
ha
; 
T
rx
R
, t
io
rr
ed
ox
in
a 
re
du
ct
as
a;
 
T
X
N
, T
hi
or
ed
ox
in
; I
kB
a,
 n
uc
le
ar
 f
ac
to
r 
of
 k
ap
pa
 li
gh
t 
po
ly
pe
pt
id
e 
ge
ne
 e
nh
an
ce
r 
in
 B
-c
el
l i
nh
ib
it
or
, a
lp
ha
.
T
a
b
l
e
 1
. 
(C
on
ti
nu
ed
)
Cardiovascular risk protection from the Mediterranean diet and olive oil • 9
Grasas Aceites 67 (4), October-December 2016, e161. ISSN-L: 0017–3495 doi: http://dx.doi.org/10.3989/gya.0451161
OO antioxidants, the OO phenolic content, the type 
of dietary fat (MUFA, SFA, carbohydrate-PUFA 
(CHO-PUFA)), and the polyphenols of red wine. 
Their aim is to unravel the transcriptional molecular 
effects of these nutrients on the underlying mecha-
nisms of processes like ageing, inflammation, oxida-
tive stress, CD40Ligand expression, blood pressure 
control, lipoprotein lipase (LPL) expression, cho-
lesterol efflux, LDL oxidation and inflammation, 
among others.
Gene expression is always measured by quanti-
tative real time-PCR (qRT-PCR) and the analyzed 
genes are those known to be relevant for specific 
pathways related to cardiovascular diseases or 
selected after a microarray. The inaccessibility of 
human tissues is an important challenge in human 
transcriptomic studies. Blood, subcutaneous adi-
pose tissue, and skeletal muscle are among the tissues 
that can be collected relatively easily. The reviewed 
studies, however, are usually carried out in periph-
eral blood mononuclear cells (PBMCs) because they 
have been reported as useful cardiovascular markers 
and their collection is viable for population-based 
studies. The trials also concur on the bases of the 
design, giving strength to the conclusions; random-
ized controlled trials can provide first-level scientific 
evidence. Multicenter trials and real-life conditions 
are encouraged to fully provide evidence for recom-
mendations to the population. Double-blind con-
ditions add robustness to the design but were not 
always possible. Other differences among them are 
the parallel/crossover design and the postprandial/
fasting sample obtainment.
The summary of findings is shown in Table 1.
3.2. Prevention through the Mediterranean diet. 
Nutrigenomic findings
Despite the high prevalence of CVD risk fac-
tors observed in Mediterranean countries, there is 
a low incidence of CVD, which can be attributed to 
some protective factors related to lifestyle, such as 
the high degree of adherence to the Mediterranean 
diet (Jousilahti et al., 1995; Strazzullo et al., 1986). 
Although the relevance of these associations is high, 
the potential interactions of different nutrients with 
lifestyle happening among the general population 
must be also considered. However, most studies are 
observational, and consequently establishing causal 
inference is hindered by residual confounding fac-
tors. Thus, large-scale randomized nutritional tri-
als and follow-up cohorts are needed to provide a 
higher level of scientific evidence.
Being overweight is an important risk factor for 
CVD but the TMD, without being a low fat diet, 
is reported to be a healthy diet and to improve the 
CVD risk (Estruch et al., 2013). Hypertension is also 
a common chronic health problem and it increases 
the risk for cardiovascular events and renal failure 
(Casas-Agustench et al., 2011). The TMD and its 
connected lifestyle are also associated with low 
blood pressure (BP) (Strazzullo et al., 1986; Casas-
Agustench et al., 2011).
The PREDIMED Study was a large, parallel-
group, multicenter, randomized, and controlled 
trial to assess the diet effects in the primary preven-
tion of CVD and intermediate biomarkers, among 
them nutrigenomic changes. Participants at high 
cardiovascular risk were randomly assigned to 
the control low-fat diet group or to the traditional 
Mediterranean diet (TMD) + Virgin Olive Oil 
(VOO) or TMD+nuts intervention groups in equal 
proportions (Estruch et al., 2013).
Llorente-Cortes et al., 2010 studied the transcrip-
tomic effect of the TMD on pro-atherotrombotic 
genes in a PREDIMED sub-sample of 49 high-car-
diovascular risk people. Their results suggested, on 
one hand, that a TMD with VOO complementation 
prevents the increase in the expression of inflam-
matory genes (such as Cyclooxygenase1 (COX-1) 
and Low density lipoprotein receptor-related pro-
tein 1(LRP1)) and reduces the expression of anti-
inflammatory ones like Monocyte chemoattractant 
protein-1 (MCP-1), compared with a low-fat diet 
and with a TMD complemented with nuts. This nut 
complementation, on the other hand, increased the 
expression of anti-thrombotic genes, such as Tissue 
factor pathway inhibitor (TFPI) and anti-foam cell 
formation such as CD36.
Castañer et al., 2013 analyzed the transcriptomic 
profile of a subsample of 34 PREDIMED par-
ticipants in which three month changes in PBMC 
were assessed. Functional annotation analysis was 
performed on responder genes selected to study 
cardiovascular canonical pathways after whole 
transcriptome microarray analyses. 43% of the 18 
cardiovascular canonical pathways were modulated 
by both TMDs, the most prevalent related to ath-
erosclerosis and hypertension. Key pathways such 
as hypoxia and endothelial nitric oxide synthase 
(eNOS) signaling where modulated by both TMDs 
whereas others, like atherosclerosis, renin-angioten-
sin, nitric oxide and angiopoietin signaling, were 
only modulated my the TMD+VOO. In addition, 
systolic blood pressure (SBP) decreased significantly 
after the TMD+VOO intervention.
Nitric oxide (NO) is a relaxing factor whereas 
endothelin-1 (ET-1) is a vasoconstrictor peptide. 
Both have an important role in the maintenance of 
vascular homeostasis and their changes are associ-
ated with a reduced BP. Storniolo et al., 2015 stud-
ied a subsample of 90 PREDIMED participants to 
assess diet-induced transcriptomic changes in blood 
pressure control elements such as nitric oxide (NO), 
ET-1 and ET-1 receptors, involved in endothelial 
dysfunction and hypertension in order to demon-
strate their correlation. They concluded that the con-
sumption of a TMD+VOO produces up-regulation 
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of NO and eNOS gene expression and the consump-
tion of a TMD+nuts produces down- regulation of 
ET-1 and ET-1 receptor gene expression.
These results indicate that the TMD, specially 
supplemented with virgin olive oil can exert changes 
in the transcriptomic response of genes related to 
cardiovascular risk, exerting health benefits, even in 
a high-risk population.
3.3. Antioxidant and anti-inflammatory properties 
of the Mediterranean diet components: 
polyphenols
The TMD is reported to have beneficial effects 
on oxidative and inflammatory conditions but the 
particular contribution of each one of the compo-
nents of the TMD separately is being studied; for 
example, virgin olive oil is known to have antioxi-
dant and anti-inflammatory properties. Other stud-
ies have centered their attention on determining the 
antioxidant and anti-inflammatory properties of 
the polyphenols of other components of the TMD, 
such as red wine, in gene expression terms.
Di Renzo et al., 2014 conducted a crossover 
postprandial trial in which 24 healthy people con-
sumed MacDonald’s or TMD based meals with or 
without red wine in order to assess the anti-oxidant 
and anti-inflammatory properties of the red wine 
polyphenols and the differences observed in the 
context of different meals. The consumption of red 
wine increased the antioxidant expression of genes 
such as catalase (CAT), Glutathione peroxidase 1 
(GPX1) and NAD-dependent deacetylase sirtuin-2 
(SIRT2),  and decreased the expression of some 
immune and inflammatory process-related genes 
such as Chemokine (C-C motif) ligand 5 (CCL5), 
independently of the meal type consumed. While 
CAT encodes a catalase that protects cells from 
the toxic effects of hydrogen peroxide such as cell 
or tissue damage, GPX1 encodes a member of the 
glutathione peroxidase family that protects the 
hemoglobin in erythrocytes from oxidative break-
down. SIRT2 encodes a member of the sirtuin 
family of proteins but its biological function and 
mechanism of action in inflammation and oxida-
tive stress is not fully understood. Finally, CCL5 is a 
chemotactic cytokine which plays diverse roles in the 
pathology of inflammatory disease. One of its duties 
consists of regulating the trafficking of Th1 T cells.
Perez Herrera et al., 2013 focused their research 
on the antioxidant properties of different oils heated 
at frying temperatures with or without antioxidant 
phenolic compounds (natural or artificially added 
antioxidants). They conducted a crossover post-
prandial trial in which 20 obese people received 4 
breakfasts consisting of different oils (VOO, sun-
flower oil (SFO) and SFO/canola oil + dimethylpo-
lysiloxane (SOX) (artificial antioxidant) or Sulphate 
of potash (SOP) (natural antioxidants from olives) 
which were subjected to 20 heating cycles. The con-
sumption of oils with natural or artificial antioxi-
dants reduced postprandial oxidative stress while 
the intake of SFO increased the gene expression of 
the different reduced Nicotinamide adenine dinu-
cleotide phosphate (NADPH)-oxidase subunits 
(Reactive oxygen species (ROS) generating enzyme), 
thus increasing the gene expression of antioxidant 
enzymes Nuclear factor (erythroid-derived 2)-like 
2 (NRF2), superoxide dismutase 1 (SOD1), CAT, 
Glutathione S-transferase P (GSTP1), Thioredoxin 
(TXN) and Glutathione Reductase (GSR), and 
causing an imbalance in the reduced glutathione/
oxidized gluthatione (GSH/GSSG ratio).
These results support the fact that different com-
ponents of the TMD, like red wine, have antioxi-
dant and anti-inflammatory properties. In addition, 
the oils with phenolic compounds, whether natural 
(VOO) or artificially added or with artificial anti-
oxidants, could reduce postprandial oxidative stress.
3.4. Long term nutrigenomic effects of the 
polyphenols of olive oil
Olive oil, as said, is the hallmark of the 
Mediterranean diet and its main source of fat.
Depending on factors such as the olive variety, 
the age of  the tree, agricultural techniques used 
in cultivation, climate and processing technique, 
among others, the content of  the phenolic com-
position of  olive oil varies in quantity (50–800 
mg/L). Virgin olive oil (VOO) is produced by direct 
pressing or centrifugation of  the olives under con-
ditions that do not alter the product. It is rich in 
phenolic compounds (around 150–400 ppm) and 
has low acidity (2.0 g/100 g maximum in European 
Union standards). Different processing methods or 
refining processes produce other olive oils such as 
ordinary or pomace olive oil in which some compo-
nents, mainly phenolic compounds, are lost (Willet 
et al., 1995).
Konstantinidou et al., 2010 also assessed the 
effect of high and low-phenolic content OO (washed 
virgin olive oil) on inflammation and oxidative stress. 
In this case, olive oils were consumed in the context 
of a TMD in a parallel clinical trial for 3 months 
by 90 healthy people. TMD and VOO resulted in 
a decreased expression of genes related to inflam-
mation (such as Interferon gamma  (IFN-γ), Rho 
GTPase Activating Protein 15 (ARHGAP15) and 
Interleukin 7 receptor alpha chain (IL7R)) and oxi-
dative stress such as Adrenoceptor Beta 2 (ADRB2).
These results were in agreement with previous 
ones concerning the fact that the benefits associ-
ated with polyphenol-rich olive oil consumption in 
cardiovascular risk could be mediated through an in 
vivo nutrigenomic effect in humans.
The EUROLIVE study was a multicenter, ran-
domized, crossover trial designed to assess the effect 
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on lipids and lipid oxidative damage in a healthy 
population of sustained doses of oil differing in 
the phenolic compound content. Participants were 
randomly assigned to 3-week intervention periods 
of 25  ml/day of raw oil administration with high, 
moderate or low phenolic contents.
Hernáez et al., 2015, Martín-Pelaez et al., 2015 
and Castañer et al., 2012 analyzed gene expression 
changes in 18 EUROLIVE subsample male partici-
pants in order to study the relation between LPL, 
blood pressure and CD40L gene expression respec-
tively and the phenolic compound contents of oil 
intake. They concluded, respectively, that phenolic 
compound-rich OO a) increases LPLgene expres-
sion, b) increases angiotensin-converting enzyme 
(ACE), Nuclear Receptor Subfamily 1, Group H, 
Member 2 (NRH1H2) and, Interleukin 8 receptor 
alpha (IL8RA) gene expression and c) decreases 
pro-atherogenic genes, CD40L and its downstream 
product gene expression: CD40L, Interleukin-
23α subunit p19 (IL23A), adrenergic β-2 receptor 
(ADRB2), oxidized LDL (lectin-like) receptor 1 
(OLR1), and Interleukin-8 receptor-α (IL8RA). 
These findings provide evidence that phenol-rich 
olive oil provides cardiovascular health benefits 
through molecular mechanisms. LPL catalyzes the 
hydrolysis of triglycerides to release free fatty acids 
into circulation, raising HDL, lowering LDL concen-
trations and improving oxidative status. The modu-
lation of genes related with the homeostasis and 
inflammation of the renin-angiotensin- aldosterone 
system could underlie the observed decrease in sys-
tolic blood pressure. CD40L and related genes are 
involved in atherogenic and inflammatory processes. 
Farras et al., 2013, followed a similar methodology 
to assess the expression of genes related to choles-
terol efflux depending on the phenolic content of 
the olive oil. The crossover trial consisted of the 
administration of 30 mL/day of high and moder-
ate polyphenol content oil during 3-week periods 
to 13 pre/hypertensive people. The results indicate 
that the intake of phenol-rich OO produces an up- 
regulation of the expression peripheral blood mono-
nuclear cells of genes related to cholesterol efflux 
from cells (ATP-Binding Cassette transporter1 
(ABCA1), Scavenger receptor class B member 1 
(SR-B1), PPAR binding protein (PPARBP), peroxi-
some proliferator-activated receptor alfa (PPARα), 
peroxisome proliferator-activated receptor betta 
(PPARγ), peroxisome proliferator-activated recep-
tor gamma (PPARδ), cluster of differentiation  36 
(CD-36) and COX-1. ABCA1 and SR-B1 are the 
main transmembrane transporters for cholesterol 
efflux. The peroxisome proliferator-activated recep-
tors (PPARs) are the nuclear receptor factor family 
involved in regulating reverse cholesterol transport-
related genes. PPARBP is a co-activator of PPARα 
and PPARγ, which have been reported to decrease 
CD40, MCP1 and other inflammatory-related 
responses. PPARδ seems to be related to an increase 
in HDL cholesterol. PPARγ up-regulates CD-36, 
a scavenger receptor that promotes the uptake of 
oxLDL and this, in turn, increases monocyte CD36 
expression (Farras et al., 2013).
Reverse cholesterol transport is crucial to prevent 
the development of atherosclerosis plaque when an 
accumulation of cholesterol in macrophages occurs. 
This accumulated cholesterol is collected by HDL 
and Apolipoprotein A1 (ApoA-1) through several 
mechanisms. HDL oxidation reduces HDL func-
tionality by impairing cholesterol efflux from mac-
rophages. Polyphenols have been shown to protect 
HDL and LDL from oxidation and modulate the 
expression of inflammation-related genes towards a 
protective mode.
These results support those of the EUROLIVE 
and demonstrate that olive oil polyphenols are able 
to modulate transduction and cell signaling through 
gene expression changes in key pathways, apart from 
scavenging free radicals. These protection effects are 
dose-dependent.
3.5. Postprandial inflammatory response to the 
polyphenols of olive oil in the context of 
different diets
The human being spends most of the time in 
a postprandial state so it is essential to know what 
changes are produced during the postprandial phase 
and how this is influenced by the quality and quantity 
of the ingested fat. That is the main reason why a lot 
of studies take their samples in a postprandial state.
In order to investigate the molecular mechanisms 
by which phenolic compounds in olive oil reduce the 
postprandial inflammatory response, some studies 
were based on transcriptomic analyses in the con-
text of different dietary patterns.
Camargo et al., 2014, conducted a crossover 
postprandial trial consisting of  the consumption 
of  different phenol contents in virgin olive oil-
based breakfasts (high, moderate and low) after 
a carbohydrate rich (CHO) diet for 6 weeks in 49 
participants with metabolic syndrome. They con-
cluded that some genes such as Interleukin-6 (IL6), 
Interleukin-1 beta (IL1B) and chemokine (C-X-C 
motif) ligand 1  (CXCL1) were down-regulated, 
implying a reduction in the postprandial inflam-
matory response.
Camargo et al., 2010, also conducted another 
parallel, postprandial trial in 20 metabolic syndrome 
people, assessing the effect of different polyphenol 
content olive oils (high content vs low content and 
control). In this case, they performed a microar-
ray analysis in which they identified differentially 
expressed genes between the groups, indicating that 
high-phenolic content VOO is associated to an anti-
inflammatory process through the gene expression 
repression mediated by the transcription factor 
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kappaB (NF-Kb), activator protein-1 transcription 
factor complex (AP-1), cytokines, mitogen-activated 
protein kinases (MAPKs) or arachidonic acid path-
ways. Many of the genes involved in these pathways 
are also relevant in other alterations such as the lipid 
profile, type 2 diabetes mellitus and obesity.
Other studies assessed the postprandial inflam-
matory response after the consumption of diets dif-
fering in their fat content.
A number of studies have shown that unsaturated 
fat (MUFA and PUFA) have beneficial effects on 
blood lipids and the inflammatory state. It has been 
reported that their consumption can improve the 
lipid profile; a MUFA-rich diet was able to reduce 
total and LDL cholesterol in moderately obese 
humans and a n-6 PUFA-enriched diet produced a 
decrease in postprandial triacylglycerol compared 
with SFA-rich butter (Gardner and Kraemer, 2011; 
Bos et al., 2010; Masson and Mensink, 2011). The 
replacement of SFA with cis-MUFA improved the 
total/HDL cholesterol ratio and if  the replacement 
was made with n-6 PUFA, postprandial tumor 
necrosis factor  alpha (TNF-α) and interleukine 
6 (IL-6) plasma levels were reduced in obese men 
(Egert et al., 2009). In northern Europe it is diffi-
cult to recommend high amounts of OO intake, so 
fat replacement with rapeseed oil has been tested. 
Rapeseed oil (RO) contains a high quantity of 
MUFA, almost as much as OO but more PUFA, 
(especially α-Linolenic  acid (ALA) and 6-linoleic 
acid) (Kratz et al., 2002). Supplementation with 
ALA is reported to reduce fasting serum triglycer-
ides in normo-lipidemic humans (Egert et al., 2009).
Obese individuals with low-grade inflammation 
have an increased risk of developing nonalcoholic 
fatty liver disease and, in this process IL-6 release 
from adipose tissue can induce hepatic insulin resis-
tance. Previous knowledge indicates that dietary fat 
composition modulation may improve nonalcoholic 
fatty liver disease, n-6 PUFA from RO reduces fat 
liver content and Eicosapentaenoic acid (EPA) pre-
vents Non-alcoholic fatty liver disease (NAFLD) 
(Smith and Adams, 2011). Kruse et al., 2015, stud-
ied the influence and postprandial inflammatory 
response of a daily nutritional supplementation of 
MUFA and PUFA in moderately obese men com-
paring a 50 g supplementation diet of OO vs RO. 
This addition caused an increase in the fat con-
sumed in both groups and the overall daily diet was 
isocaloric in order to not confound the effects of 
weight change with the oil supplementation. In the 
RO group, there was a postprandial gene expression 
increase of IL1B and IL6 (pro-inflammatory cyto-
quines), Chemokine (C-C motif) ligand 2 (CCL2) 
and EGF-like module containing a mucin-like hor-
mone receptor (EMR1) which increases macrophage 
invasion in adipose tissue; and of CCL2 in the OO 
group; all of them are known up-regulated mark-
ers in the chronic inflammation occurring in obesity. 
They also observed a reduced long-term IL6 gene 
expression after RO consumption. These results 
indicate that RO consumption in nonalcoholic fatty 
liver disease reduces serum enzymes and has a ben-
eficial postprandial inflammation response.
Pietraszek et al., 2014, assessed the effects of 
monounsaturated fat on postprandial lipemia and 
gene expression in first-degree relatives of subjects 
with type 2 diabetes. Their conclusions were that 
a MUFA-rich meal elicits similar postprandial tri-
glyceridemia, insulin and incretin responses in type 
2 diabetes relatives and the control group, but has a 
differential impact on gene expression pointing to 
early defects in lipid metabolismin type 2 diabetes 
relatives.
All these results suggest that dietary fat content 
modulates postprandial inflammatory response and 
provokes a differential gene expression. Moreover, 
personal genotypes or conditions such as obe-
sity can also be differentially modulated by the fat 
consumed.
In the following section we present other exam-
ples of reviewed trials, which are based on a fatty 
breakfast after a certain diet.
Bellido et al., 2004 studied the effect of the intake 
of meals with three different fat composition on the 
postprandial activation of NF-kB, which results in 
immune and inflammatory gene responses. They 
conducted a crossover postprandial trial in which 8 
healthy men consumed an OO-based meal differing 
in fat composition (MUFA, SFA and MUFA-SFA-
PUFA rich) after 4 weeks of washout consisting of a 
baseline diet. Their results suggest that NF-kB acti-
vation could be one of the reasons for the cardio-
protective effect observed by MUFA-rich fat intake 
such as OO. Jimenez-Gomez et al., 2009, conducted 
a similar crossover postprandial clinical trial in 
which 20 healthy men were also tested for their tran-
scriptomic response related to inflammation after a 
fatty breakfast intake in participants that had fol-
lowed three different types of diets: SFA (Western), 
TMD+VOO (MUFA), CHO-rich and n-3 rich diets. 
The gene expression of TNF-alpha was higher 
after breakfast in the group that had consumed the 
SFA diet while the IL-6 expression was lower in the 
group that followed the PUFA diet. Both genes are 
involved in inflammation processes and their tran-
scriptomic changes might underlie cardio-protective 
effects due to the intake of VOO and nuts.
Meza-Miranda et al., 2014, and Camargo et al., 
2012, conducted a crossover postprandial trial in 20 
healthy elderly people who followed three diets for 
3-week periods each. The diets differed in the fat 
type; SFA-rich, TMD+VOO (MUFA) and CHO-
PUFA. After a breakfast with a similar composi-
tion to the final dietary period, samples of adipose 
tissue and blood (PBMCs) where taken in order to 
assess the nutrigenomic changes related to oxidative 
stress and inflammatory response, depending on 
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the dietary fat administered. Meza-Miranda et al., 
2014 and Camargo et al., 2012, showed an increase 
in the postprandial gene expression profile of the 
antioxidant defense system due to the consumption 
of TMD and CHO-PUFA diet compared with the 
SFA-rich diet. Camargo et al., 2012 observed that 
TMD (MUFA) consumption reduces the expression 
of several inflammatory genes compared to SFA-
rich (p65 and MCP-1) and CHO-PUFA diets (p65 
and TNF-a), increases the expression of the anti-
inflammatory gene IkBa and decreases the MMP-9 
plaque instability marker gene expression.
All these results suggested that the in vivo post-
prandial response happening after a meal can be 
regulated by the dietary fat intake; and that TMD, 
rich in MUFA, provides protection against oxida-
tive stress and inflammation.
4. LIMITATIONS
All the studies selected for the review have robust 
designs, but the subsamples chosen for the tran-
scriptomic analysis and the periods provided are still 
small to fully guarantee the results, although they 
have improved with time.
The main limitation of all these studies is the 
potential interaction between the components in 
the study and others in the diet that might affect the 
generalization of the results. When studying the 
effects after TMD consumption due to MUFA 
content, it could be possible that they are due to 
minor components in olive oil or a combination of 
both. When studding the differences among phenol 
content intake it is possible that the phenol intake 
comes from other diet components aside from the 
olive oil.
5. FUTURE
Confirmation of the results in different and 
larger populations, longer intervention periods and 
evaluation of the gene expression changes in human 
tissues, other than PBMCs, are still needed.
The future of high-throughput techniques with 
new and more accessible capacities for nutrigenom-
ics, as well as the advance in the study of the pro-
teome and the metabolome will lead to the integrated 
systems biology that will allow for a better and more 
complete understanding of the global changes in the 
cell and the organism. That information will provide 
the understanding of the molecular mechanisms 
underlying the transcriptomic changes which are 
still not clear in many cases. These approaches will 
allow for the detection of new biomarkers of inter-
est and the advance towards protective cardiovascu-
lar medicine through diet and even to personalized 
genomic advice.
Genome-wide association studies (GWAS) are a 
very useful technique in the determination of single 
nucleotide polymorphisms (SNPs) and genomic 
variations which can predispose disease. The inte-
gration with transcriptome information can reveal 
the effect of diet modulation on certain genotypes. 
In depth cardiovascular research with these meth-
ods will be very useful.
6. CONCLUSIONS
16 clinical trials in humans assessing the nutrig-
enomic effects of the Mediterranean diet or some 
of its components on cardiovascular risk or related 
processes have been analyzed. There are differences 
among study designs and lack of end-point homo-
geneity as the outcomes and constituents evaluated 
are different, but the methodology is similar, in gen-
eral qRT-PCR in reported or selected by microarray 
genes from PBMCs has been used.
The Mediterranean diet is a healthy diet that 
can exert changes in the transcriptomic response 
of  genes related to cardiovascular risk, especially 
supplemented with virgin olive oil. Atherosclerosis, 
hypertension and blood pressure are some of  the 
most relevant pathways modulated with diet and 
the health benefits turn out to be more beneficial 
than those from a low-fat diet. The consumption 
of  the TMD and VOO produces up-regulation 
of  NO and eNOS gene expression and TMD and 
nuts down-regulate ET-1 and ET-1 receptor gene 
expression. These genes are involved in endo-
thelial dysfunction and hypertension and their 
changes are associated with low BP (Storniolo 
et al., 2015).
The TMD plays an important role in key path-
ways such as hypoxia and eNOS signaling. In addi-
tion, it increases the postprandial gene expression 
profile of the antioxidant defense system and there-
fore, the ROS detoxification rate in adipose tissue. 
The TMD reduces the expression of several inflam-
mation genes such as p65 and MCP-1 compared 
with SFA-rich and CHO-PUFA diets (p65 and 
TNF-α) and increases the expression of the anti-
inflammatory gene IkBa and decreases the MMP-9 
plaque instability marker gene expression (Camargo 
et al., 2012).
Among the TMD components, polyphenols have 
anti-inflammatory and antioxidant properties. The 
consumption of red wine, for example, increases the 
antioxidant expression of genes such as CAT, GPX1 
and SIRT2, while it decreases some immune and 
inflammatory process-related gene expression such 
as CCL5. Oils with phenolic compounds, natural 
(VOO) or artificially added and even after heated at 
frying temperature, are able to reduce postprandial 
oxidative stress while the consumption of polyphe-
nols and antioxidant-lacking oils like sunflower pro-
duce the inverse effect.
The properties of polyphenols are dose- dependent 
and the high content polyphenol oils are the healthiest. 
14 • S. Carrión, L. Torres and O. Castañer
Grasas Aceites 67 (4), October-December 2016, e161. ISSN-L: 0017–3495 doi: http://dx.doi.org/10.3989/gya.0451161
Phenol-rich olive oil produces cardiovascular health 
benefits, lowering its risk factors, through molecular 
mechanisms modulating cell signaling gene expres-
sion pathways, apart from the effects of the scaveng-
ing of free radicals. Some of these transcriptional 
modulations are the increase in LPL (hydrolysis of 
triglycerides to release free fatty acids into circulation, 
HDL cholesterol rise, lower LDL concentrations and 
improvement in oxidative status), which reduces the 
inflammation and oxidative stress. ACE, NRH1H2 
and IL8RA expression are modulated by phenol rich 
OO and these genes are involved in homeostasis and 
inflammation of the renin- angiotensin-aldosterone 
system. The consumption of phenol-rich OO also 
up-regulates the expression of cholesterol efflux from 
cells to HDL related genes such as ABCA1, SR-B1, 
PPARBP, PPARα, PPARγ, PPARδ, CD-36 and 
COX-1. Equally important, it reduces the expression 
of pro-atherogenic genes, down-regulating CD40L 
expression and its downstream products related to 
atherogenic and inflammatory processes. Fat type 
and content in oils and diets also modulates post-
prandial inflammatory response and gene expression. 
MUFA-rich diets, such as TMD, provide protection 
from oxidative stress and inflammation. Their con-
sumption reduces the gene expression of several 
inflammatory (such as p65, MCP 1 and TNF) and 
plaque instability genes and increases the expression 
of anti-inflammatory genes.
IL1B, IL6, CXCL1, INF-γ, ARHGAP15 and 
IL7R are genes related to postprandial inflammatory 
response and ADRB2 is related to oxidative stress 
whose expression is decreased by the consumption of 
TMD and VOO. In addition, the transcription fac-
tor NF-Kb mediates different inflammatory path-
ways that involve several genes that are differentially 
expressed depending on the phenol-content intake, 
underlying the high relevance of the diet in inflam-
matory processes.
Processes that lead to a rise in chronic inflamma-
tion and oxidative stress, such as cardiovascular, neu-
rodegenerative diseases, and aging could be treated 
and/or prevented through dietary intervention. 
The Mediterranean diet with its richness in poly-
phenols and MUFA components induces transcrip-
tomic gene expression variations that trigger healthy 
and cardio-protective effects.
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